3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
24
Colorectal Neoplasms
16
Small Cell Lung Carcinoma
6
Stomach Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Recurrence
3
Rectal Neoplasms
3
Osteosarcoma
3
Ovarian Neoplasms
2
Nasopharyngeal Carcinoma
2
Glioma
2
Glioblastoma
2
Gastrointestinal Neoplasms
2
Fallopian Tube Neoplasms
2
Esophageal Neoplasms
2
Cholangiocarcinoma
2
Wilms Tumor
1
Weight Loss
1
Triple Negative Breast Neoplasms
1
Somatostatinoma
1
Solid Tumor Cancer
1
Solid Tumor
1
Small Cell Lung Cancer Extensive Stage
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Interventions
Hyperthermic Intraperitoneal Chemotherapy
27
Cisplatin
17
Oxaliplatin
16
Cytoreduction Surgical Procedures
15
Paclitaxel
12
Fluorouracil
10
Mitomycin
8
Leucovorin
8
Doxorubicin
7
Docetaxel
5
Neoadjuvant Therapy
4
Blood Specimen Collection
4
Taxes
3
Surgical Procedures, Operative
3
Chemotherapy, Adjuvant
3
Carboplatin
3
Bevacizumab
3
catumaxomab
2
Platinum
2
Palliative Care
2
Observation
2
Nivolumab
2
Mitozytrex
2
Laparoscopy
2
Interviews as Topic
2
Indocyanine Green
2
Folfox protocol
2
Albumin-Bound Paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
tremelimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Peritoneal Neoplasms
×
irinotecan sucrosofate
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled